The New York Mets have announced the re-signing of right-handed reliever Drew Smith to a one-year contract with a club option for the 2026 season. Smith, who has been with the Mets since 2017, is currently rehabilitating from his second Tommy John surgery, which he underwent in July 2024. This move underscores the organization’s commitment to Smith’s recovery and their belief in his potential future contributions to the bullpen.
Drew Smith’s Journey with the Mets
Drew Smith was acquired by the Mets in July 2017 from the Tampa Bay Rays in exchange for first baseman Lucas Duda. He made his major league debut with the Mets in 2018, appearing in 27 games and posting a 3.54 ERA. Over the subsequent seasons, Smith became a reliable figure in the Mets’ bullpen, known for his resilience and effective pitching.
In 2022, Smith was part of a combined no-hitter against the Philadelphia Phillies, pitching 1.1 innings in relief. This historic game marked the first no-hitter for the Mets since Johan Santana’s in 2012.
Injury and Rehabilitation
Smith’s career has been marred by injuries, most notably two Tommy John surgeries. The first surgery caused him to miss the entire 2019 season. In June 2024, Smith was placed on the injured list due to a right elbow sprain, which led to his second Tommy John surgery in July 2024. This procedure typically requires a lengthy rehabilitation process, often sidelining pitchers for 12 to 18 months.
Given the timing of his surgery, it’s uncertain whether Smith will be able to return to the mound during the 2025 season. However, the inclusion of a club option for 2026 in his new contract indicates the Mets’ optimism about his recovery and their interest in retaining him for future seasons.
Contract Details and Implications
While specific financial terms of the contract have not been disclosed, the structure—a one-year deal with a club option for 2026—provides benefits for both parties. For Smith, it offers financial security and the opportunity to focus on his rehabilitation within the Mets organization. For the Mets, it ensures that if Smith returns to form, they have the option to retain him for the 2026 season at a predetermined salary.
This approach reflects a growing trend in Major League Baseball, where teams sign injured players to short-term deals with options, allowing them to manage risk while supporting the player’s recovery.
Smith’s Perspective and Future Outlook
After his surgery in July 2024, Smith expressed his deep connection to the Mets organization, stating, “I’ve been with the Mets for a long time, and I love this organization. They’ve done a lot for me over the years.” His sentiments highlight the mutual respect and loyalty between Smith and the Mets, factors that likely influenced the decision to bring him back despite his injury.
Looking ahead, Smith’s focus will be on a successful rehabilitation with the aim of returning to the mound. If his recovery progresses well, he could be a valuable asset for the Mets in the latter part of the 2025 season or, more likely, in 2026.
Conclusion
The Mets’ decision to re-sign Drew Smith underscores their commitment to their players and their strategic approach to building a resilient bullpen. By investing in Smith’s recovery, the organization not only supports a player who has been a consistent contributor but also positions itself to benefit from his talents in future seasons. Fans will undoubtedly be eager to see Smith return to the mound, continuing his journey with the Mets.
Finn has over 10 years of rich experience as an SEO expert, writer, and digital media professional, where he has led dynamic teams of anchors, reporters, and editors to create compelling news broadcasts. His leadership in the newsroom has helped deliver coverage on some of the most significant and impactful news stories of the time, ensuring that each story reaches its audience in the most engaging and informative manner.
Leave a Reply